close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Oculis Holding AG - Ordinary shares (NQ:OCS)

14.81 -7.88 (-34.74%)
Streaming Delayed Price Updated: 1:05 PM EDT, Jun 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Oculis Holding AG - Ordinary shares

< Previous 1 2 3 Next >
News headline image
Expert Ratings for Oculis Holding ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023 ↗
 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Oculis Holding ↗
 
Via Benzinga
News headline image
Expert Ratings for Oculis Holding ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023 ↗
 
Via Benzinga
News headline image
Oculis Announces Partial Exercise of Underwriters’ Option to Purchase Additional Ordinary Shares
From Oculis SA
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2023 ↗
 
Via Benzinga
News headline image
Stonegate Healthcare Partners Announces Publishing of a Thematic Report - Beyond VEGF: Therapies Revolutionizing Diabetic Eye Disease
Dallas, Texas--(Newsfile Corp. - June 1, 2023) - Stonegate Healthcare Partners (SHP), a healthcare... 
Via Newsfile
News headline image
Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares
From Oculis SA
Via GlobeNewswire
News headline image
Intel, Noah Holdings, Twilio And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. SunCar Technology Group Inc. (NASDAQ: SDA) shares gained... 
Via Benzinga
News headline image
Oculis Announces Launch of Proposed Public Offering of Ordinary Shares
From Oculis SA
Via GlobeNewswire
News headline image
Oculis to Participate and Present at Upcoming EuDES Meeting
From Oculis SA
Via GlobeNewswire
News headline image
Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye Drops
From Oculis SA
Via GlobeNewswire
News headline image
Oculis Co-founders Selected as Finalists in European Inventor Award 2023
From Oculis SA
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023 ↗
 
Via Benzinga
News headline image
Oculis Opens New Offices in the US and Expands its US Team by Appointing Dr. Fang Li as Senior Vice President, Regulatory Affairs
From Oculis SA
Via GlobeNewswire
News headline image
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Harley-Davidson, Sportsman's Warehouse And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Oculis to Participate at Upcoming Investor Conferences
From Oculis SA
Via GlobeNewswire
News headline image
Oculis to Host Conference Call on April 13, 2023 to Discuss Late-Stage Pipeline and Near-Term Clinical Milestones
From Oculis SA
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  On Monday, 89 stocks made new 52-week lows. 
Via Benzinga
News headline image
Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing
From Oculis SA
Via GlobeNewswire
News headline image
Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial
From Oculis SA
Via GlobeNewswire
News headline image
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today